Jade Biosciences's market cap is currently $276.67M. The company's EPS TTM is $-0.86; its P/E ratio is ―; and it has a dividend yield of 28.30%. Jade Biosciences is scheduled to report earnings on August 13, 2025, and the estimated EPS forecast is $-0.55. See an overview of income statement, balance sheet, and cash flow financials.
